Loading...

Euroespes, S.A.

EEP.MCEURONEXT
Healthcare
Medical - Diagnostics & Research
0.54
0.00(0.00%)
U.S. Market opens in 5h 25m

Euroespes, S.A. (EEP.MC) Stock Competitors & Peer Comparison

See (EEP.MC) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Diagnostics & Research Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
EEP.MC€0.54N/A6.2M-54.00-€0.01N/A
ERF.PA€62.40+0.52%11.1B24.60€2.55+0.96%
BIM.PA€91.80+2.68%10.8B27.38€3.34+0.98%
LBIRD.PA€20.60+2.49%447M42.29€0.48N/A
MDXH.BR€3.02-3.76%85.6M-1.58-€1.91N/A
ALECR.PA€16,100.00+0.00%81.2M13.17€1,222.20N/A
BCART.BR€0.29+0.00%27.2M-0.32-€0.92N/A
ALBIO.PA€0.79-0.75%14.7M-0.20-€3.98N/A
ALPRE.PA€3.08-0.32%12.1M-2.92-€1.06N/A
MLAHC.PA€0.60+0.00%5.4M-10.00-€0.06N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

EEP.MC vs ERF.PA Comparison April 2026

EEP.MC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EEP.MC stands at 6.2M. In comparison, ERF.PA has a market cap of 11.1B. Regarding current trading prices, EEP.MC is priced at €0.54, while ERF.PA trades at €62.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EEP.MC currently has a P/E ratio of -54.00, whereas ERF.PA's P/E ratio is 24.60. In terms of profitability, EEP.MC's ROE is N/A, compared to ERF.PA's ROE of +0.12%. Regarding short-term risk, EEP.MC is more volatile compared to ERF.PA. This indicates potentially higher risk in terms of short-term price fluctuations for EEP.MC.Check ERF.PA's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions